AbCellera Biologics (ABCL) Earnings Date & Reports

AbCellera Biologics Inc is an antibody discovery and development engine thatâ€™s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABCL is expected to report earnings to -14 cents per share on August 12

AbCellera Biologics ABCL Stock Earnings Reports

Q2'25

Est.

$-0.14

Q1'25

Missed

by $0.01

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.01

The last earnings report on May 08 showed earnings per share of -14 cents, missing the estimate of -12 cents. With 2.34M shares outstanding, the current market capitalization sits at 593.98M.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+30%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

ABCL